• The agreement also covers the co-development of 3D printed concepts and prototypes for pharmaceutical and complementary medicine, creating novel approaches to health and wellness
Brenntag, the global market leader in chemical and ingredients distribution, today announced the appointment as distributor for Craft Health, Southeast Asia’s first and only 3D printing technology company offering customized solutions for drug delivery, with end-to-end solutions from research and development to manufacturing for the pharmaceuticals and nutraceuticals industries.
Craft Health’s 3D technology represents a leap forward in medical innovation, enabling the creation of personalized tablets that can be customized in terms of shape, dosage, and active ingredient delivery.
Romain Girard, Regional President, Pharma APAC, Brenntag Specialties, said, “Brenntag has a broad portfolio of world-class suppliers and value-added services, and our collaboration with Craft Health is highly compatible with our global Pharma strategy. This partnership is a game-changer for the pharmaceutical and complementary medicine segments, and I can’t wait to bring the transformative 3D technology to our customers, empowering them to deliver personalized treatments that enhance patient outcomes.”
“Craft Health is excited to collaborate with Brenntag in this groundbreaking partnership. By combining our expertise and optimizing synergies in automating mass customization using our proprietary 3D printing systems for pharmaceuticals and nutraceuticals with Brenntag’s vast knowledge in chemical distribution and quality products, we aim to push the boundaries of innovation and bring transformative solutions to the healthcare industry,” said Dr Wei Jiang GOH, CEO at Craft Health.
3D printing technology for pharmaceutical and nutraceutical applications offers several distinct advantages, including:
• Versatility in active ingredients: The 3D printing process is heat-free and UV-free, performed at room temperature and pressure, allowing the use of a wide range of active ingredients, including heat-sensitive materials and probiotics.
• Innovative product design: The mold-free production technique enables the creation of complex and novel geometries in food and supplement products, opening new possibilities for product innovation.
• Controlled release profiles: Customizable release profiles can be achieved, offering tailored solutions for specific therapeutic needs.
• Rapid prototyping and low minimum order quantities (MOQs): The technology allows for rapid prototyping of innovative formats with the flexibility to produce low quantities, catering to niche markets and specialized patient needs.
www.brenntag.com
